home / stock / ngenf / ngenf short
Short Information | NervGen Pharma Corp (OTCMKTS:NGENF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 406,462 |
Total Actual Volume | 967,472 |
Short Trends | |
---|---|
Cover Days | 8 |
Short Days | 7 |
No Change Days | 5 |
Averages | |
---|---|
Average Short Volume | 20,323 |
Average Short Percentage | 41.56% |
Is there a NGENF Short Squeeze or Breakout about to happen?
See the NGENF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-02-2024 | $1.49 | $1.6 | $1.61 | $1.49 | 92,409 | 36,132 | 39.1% |
05-01-2024 | $1.53 | $1.48 | $1.5315 | $1.48 | 14,535 | 4,374 | 30.09% |
04-30-2024 | $1.5 | $1.52 | $1.58 | $1.49 | 43,270 | 19,122 | 44.19% |
04-29-2024 | $1.55 | $1.5 | $1.57 | $1.5 | 43,385 | 23,731 | 54.7% |
04-26-2024 | $1.5025 | $1.55 | $1.58 | $1.5025 | 50,284 | 4,850 | 9.65% |
04-25-2024 | $1.52 | $1.5 | $1.56 | $1.47 | 51,535 | 29,767 | 57.76% |
04-24-2024 | $1.53 | $1.53 | $1.61 | $1.5 | 59,050 | 33,398 | 56.56% |
04-23-2024 | $1.556 | $1.53 | $1.63 | $1.53 | 20,509 | 16,244 | 79.2% |
04-22-2024 | $1.636 | $1.57 | $1.636 | $1.54 | 30,114 | 20,139 | 66.88% |
04-19-2024 | $1.5 | $1.59 | $1.625 | $1.455 | 63,046 | 39,310 | 62.35% |
04-18-2024 | $1.45 | $1.45 | $1.47 | $1.4 | 62,580 | 45,255 | 72.32% |
04-17-2024 | $1.49 | $1.4315 | $1.49 | $1.42 | 68,184 | 33,432 | 49.03% |
04-16-2024 | $1.64 | $1.48 | $1.64 | $1.45 | 34,434 | 12,144 | 35.27% |
04-15-2024 | $1.56 | $1.5 | $1.57 | $1.5 | 54,594 | 9,495 | 17.39% |
04-12-2024 | $1.57 | $1.57 | $1.6 | $1.56 | 15,771 | 3,896 | 24.7% |
04-11-2024 | $1.59 | $1.575 | $1.59 | $1.54 | 39,375 | 8,757 | 22.24% |
04-10-2024 | $1.51 | $1.61 | $1.61 | $1.5 | 63,536 | 26,832 | 42.23% |
04-09-2024 | $1.61 | $1.5415 | $1.61 | $1.5415 | 32,027 | 4,840 | 15.11% |
04-08-2024 | $1.58 | $1.61 | $1.66 | $1.58 | 27,558 | 6,882 | 24.97% |
04-05-2024 | $1.66 | $1.64 | $1.67 | $1.58 | 101,276 | 27,862 | 27.51% |
News, Short Squeeze, Breakout and More Instantly...
NervGen Pharma Corp Company Name:
NGENF Stock Symbol:
OTCMKTS Market:
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that it has engaged...
Anticipated completion of enrollment of the chronic cohort in the Phase 1b/2a clinical trial in Q2 2024 CA$23 million bought deal financing completed in March 2024 provides expected cash runway through Q3 2025 Fast Track designation granted by U.S. Food and Drug Administration (FDA) for NV...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (" NervGen " or the " Company ") is pleased to announce the closing of its previously ann...